Home › Funds › Michelson Medical Research Foundation, Inc. › IVE

Michelson Medical Research Foundation, Inc. position in IVE

ISHARES TR

Michelson Medical Research Foundation, Inc. reported holding 51,905 shares of IVE (ISHARES TR) in its Q3 2026 13F filing — a position valued at US$11.8M, representing 10.53% of its reported portfolio and ranking #2 among its reported holdings. Michelson Medical Research Foundation, Inc. has disclosed IVE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)51.91K sh
Reported value held$11.85M
Portfolio Weight10.53%
First reportedQ3 2023
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Michelson Medical Research Foundation, Inc.'s IVE position evolved

Michelson Medical Research Foundation, Inc. first disclosed a stake in IVE in Q3 2023 at 51,905 shares (US$8.0M). The position peaked in Q3 2026 at 51,905 shares, worth US$11.8M. Across 13 filings, Michelson Medical Research Foundation, Inc. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 51,905 shares valued at US$11.8M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 51.91K $7.99M New
Q4 2023 51.91K $9.03M Hold
Q1 2024 51.91K $9.70M Hold
Q2 2024 51.91K $9.45M Hold
Q3 2024 51.91K $10.23M Hold
Q4 2024 51.91K $9.91M Hold
Q1 2025 51.91K $9.89M Hold
Q2 2025 51.91K $10.14M Hold
Q3 2025 51.91K $10.72M Hold
Q4 2025 51.91K $11.01M Hold
Q1 2026 51.91K $10.96M Hold
Q2 2026 51.91K $11.79M Hold
Q3 2026 51.91K $11.85M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IVE and 13F data

IVE (ISHARES TR) is a company whose sector is not yet classified in our data. 26 other funds we track also report a position in IVE — the largest reported positions include ENVESTNET ASSET MANAGEMENT INC (US$5.98B), JPMorgan Chase & Co (US$3.65B), LPL Financial LLC (US$2.24B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IVE

All IVE fund holders →

FAQ

How long has Michelson Medical Research Foundation, Inc. held IVE?

Michelson Medical Research Foundation, Inc. has disclosed IVE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Michelson Medical Research Foundation, Inc.'s current position in IVE?

As of Q3 2026, Michelson Medical Research Foundation, Inc. holds 51.91K shares of IVE (ISHARES TR), valued at $11.85M, representing 10.53% of its reported portfolio and ranking #2.

Has Michelson Medical Research Foundation, Inc. been buying or selling IVE?

In the latest 13F filing (Q3 2026), Michelson Medical Research Foundation, Inc. held unchanged its position in IVE. The position peaked in Q3 2026 at 51.91K shares.

Which other funds hold IVE?

Other major institutional holders of IVE include ENVESTNET ASSET MANAGEMENT INC, JPMorgan Chase & Co, LPL Financial LLC, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.